Christopher D. Lueking

  • 330 North Wabash Avenue, Suite 2800
  • Chicago, IL 60611
  • USA
Profile Experience

Christopher Lueking is in his 34th year of practice with Latham & Watkins. Mr. Lueking advises clients on corporate finance, securities, and public and private company representation, including initial public, secondary, SPAC, high yield bond, and private securities offerings. He also counsels companies on securities and corporate governance matters.

Mr. Lueking’s practice includes representing issuers and investment banks in public offerings of equity and high yield debt as well as investors and issuers in venture capital transactions.

Mr. Lueking’s representations in initial public offerings, deSPACs, and other financing transactions in recent years include:

  • Tritium DCFC Limited
  • Harmony Biosciences
  • Viking Cruise Lines
  • Sprout Social
  • VistaGen Therapeutics
  • Mayville Engineering Company
  • PetIQ
  • Construction Partners Inc.
  • John Bean Technologies Corporation
  • Primo Water
  • OrthoPediatrics
  • Assembly Biosciences
  • NetSmart
  • Duluth Trading
  • Athersys
  • Spring Bank Pharmaceuticals
  • CNH Industrial Capital
  • Textura Corporation
  • Orbitz
  • Eagle Pharmaceuticals
  • BioDelivery Sciences International
  • Pfenex

Mr. Lueking has represented a number of investment banking clients in a variety of public offering underwritings and high yield offerings during the past several years, including:

  • J.P. Morgan
  • Barclays
  • Citigroup
  • Morgan Stanley
  • Bank of America/Merrill Lynch
  • Credit Suisse
  • William Blair & Company
  • Stifel Nicolaus Weisel
  • Robert W. Baird
  • Goldman, Sachs & Co.
  • Piper Sandler
  • Jefferies

His ongoing representation of public and private companies in corporate governance and securities matters includes work for:

  • Aon
  • Tritium
  • Harmony Biosciences
  • Castle Creek Biosciences
  • VistaGen Therapeutics
  • Libbey
Recent Speaking Engagements
  • Latham/PwC “Going Public and Being Public – Planning a Successful IPO” seminars – Chicago, Minneapolis, Denver and Salt Lake City
  • Stifel IPO seminar - New York
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.